Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010084199) DRUG DELIVERY SYSTEM FOR USE IN THE TREATMENT OF VASCULAR AND VESSEL-RELATED PATHOLOGIES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/084199 International Application No.: PCT/EP2010/050833
Publication Date: 29.07.2010 International Filing Date: 26.01.2010
IPC:
A61K 9/127 (2006.01) ,A61K 31/198 (2006.01) ,A61K 47/48 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
127
Liposomes
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
197
the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198
Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
48
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Applicants:
ACADEMISCH MEDISCH CENTRUM [NL/NL]; Postbus 22700 NL-1100 DE Amsterdam, NL (AllExceptUS)
HEGER, Michal [NL/NL]; NL (UsOnly)
Inventors:
HEGER, Michal; NL
Agent:
VAN SOMEREN, Petronella Francisca Hendrika Maria; Sweelinckplein 1 NL-2517 GK Den Haag, NL
Priority Data:
09151332.526.01.2009EP
Title (EN) DRUG DELIVERY SYSTEM FOR USE IN THE TREATMENT OF VASCULAR AND VESSEL-RELATED PATHOLOGIES
(FR) SYSTÈME D'ADMINISTRATION DE MÉDICAMENT DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE PATHOLOGIES VASCULAIRES ET DE PATHOLOGIES LIÉES AUX VAISSEAUX
Abstract:
(EN) The present invention relates to a drug delivery system for use in the treatment of vascular and vessel-related pathologies, comprising a drug delivery platform that comprises at least one compound capable of exerting an effect on the formation and/or maintenance of a thrombus in the vessel to be treated. The platform is preferably formed by liposomes that are sterically stabilized by grafting of poly(ethylene glycol) onto the liposome surface. The liposomes may further comprise photosensitizers and targeting molecules. The liposomes may be thermosensitive. The compound is suitably tranexamic acid. The drug delivery system is preferably used for the treatment of port wine stains.
(FR) La présente invention concerne un système d'administration de médicament destiné à être utilisé dans le traitement de pathologies vasculaires et de pathologies liées aux vaisseaux. Ledit système comprend une plateforme d'administration de médicament qui comporte au moins un composé capable d'exercer un effet sur la formation et/ou la maintenance d'un thrombus dans le vaisseau devant être traité. Ladite plateforme est, de préférence, formée par des liposomes qui sont stabilisés stériquement par greffe de poly(éthylène glycol) sur la surface desdits liposomes. Ces liposomes peuvent en outre comprendre des photosensibilisateurs et des molécules de ciblage. Les liposomes peuvent être thermosensibles. Ledit composé est, de manière adaptée, un acide tranexamique. Ledit système d'administration de médicament est de préférence utilisé dans le traitement de l'angiome plan.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2389157US20120010557CN102300557IN6271/DELNP/2011